Type 2 (T2)-high asthma, characterized by eosinophilic inflammation and elevated IL-4, IL-5, and IL-13 pathways, has been associated with a more robust Th2 response, which may mitigate the hyperinflammatory state triggered by SARS-CoV-2 infection [76,77]. Here, IL13 is linked to asthma.